Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland.
Credit: National Institute of Allergy and Infectious Diseases, NIH
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings.
The COVID-19 Clinical Research Coalition aims to accelerate desperately needed COVID-19 research in those areas where the virus could wreak havoc on already-fragile health systems and cause the greatest health impact on vulnerable populations.
In a Comment published today in The Lancet, the members of the coalition argue that international research collaboration and coordination is needed urgently to support African, Latin American, Eastern European, and certain Asian countries to respond effectively to the worsening pandemic and speed up research adapted to resource-limited settings.
The coalition brings together an unprecedented array of health experts, including public-sector research institutes, ministries of health, academia, not-for-profit research and development organizations, NGOs, international organisations, and funders all committed to finding COVID-19 solutions for resource-poor settings.
One important research response to COVID-19 has been launched already, the World Health Organization (WHO)-led SOLIDARITY trial, an unprecedented global effort. But the authors found that out of almost 600 COVID-19 clinical trials registered, very few trials are planned in resource-poor settings. The authors commit to sharing their technical expertise and clinical trial capability to accelerate COVID-19 research in these settings.
The scale of the challenge is clearly beyond the scope of any single organization. The coalition will facilitate a coordinated approach, so that all data from all regions can be collected in a similar fashion, pooled and shared in real-time. This will help countries and the WHO to make rapid evidence-based decisions on policies and practice.
“We welcome the launch of this coalition, which takes advantage of existing multinational and multidisciplinary expertise in running clinical trials in resource poor settings, and will help the World Health Organization in its coordinating role in the global response to COVID-19,” said Dr Soumya Swaminathan, Chief Scientist, World Health Organization. “Although the epicentre is today elsewhere, we must prepare now for the consequences of this pandemic in more resource-constrained settings or we stand to lose many more lives.”
Members of the coalition call for specific commitments to ensure access, so that effective new treatments are made available as soon as possible in resource-poor settings and are affordable and readily accessible.
So far more than 70 organizations have joined this coalition, with a call made to other organizations ready to contribute existing capacity to join. Please contact the COVID-19 Clinical Research Coalition for more information: [email protected]
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19 in resource-poor settings
- State unclear on impact of COVID-19 clawback in debt ceiling deal
State leaders are still unsure exactly how COVID-19 rescission in the federal debt ceiling deal will impact funding Indiana received or was set to receive.
- Do veterans with COVID-19 experience similar outcomes when hospitalized in Veterans Health Administration hospitals vs. community hospitals?
The present study showed that veterans experienced markedly higher risk-adjusted mortality in community hospitals than VHA hospitals. In contrast to mortality, re-admission rates were slightly higher ...
- How to Spend $30 Million in COVID-19 Relief Funds
FEMA allotted St. Clair County more than $50 million to help it respond to and recover from COVID. The money came from the Coronavirus State and Local Fiscal Recovery Funds program authorized by the ...
- Best Covid-19 Travel Insurance Plans Of June 2023
Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Covid is still throwing uncertainty into many people’s ...
- Living Better: What it takes to get healthy in America
Poor diet, lack of exercise, stress and trauma, all drive America's declining life expectancy and high rates of chronic disease. So how can we live better in America? NPR looks for answers.
Go deeper with Google Headlines on:
COVID-19 in resource-poor settings
[google_news title=”” keyword=”COVID-19 in resource-poor settings” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Prevention and treatment of COVID-19
- With COVID-19 public health emergency ending, Maine CDC website to stop updating vaccination numbers
May 5—The Maine Center for Disease Control and Prevention is scaling back information ... "The site will focus on providing vaccine, testing and treatment information for COVID-19. Vaccination remains ...
- FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
In considering approval of a drug, the FDA conducts a benefit-risk assessment based on rigorous scientific standards to ensure that the product’s benefits outweigh its risks for the intended ...
- IC closes COVID-19 testing location and ends wraparound care
Ithaca College put an end to its remaining COVID-19 infrastructure and policies, like testing locations and dedicated quarantine spaces, May 31.
- U.S. Food and Drug Administration approves the oral antiviral Paxlovid for the treatment of mild-to-moderate COVID-19 in adults
INDIANA - Today, the U.S. Food and Drug Administration approved the oral antiviral Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate ...
- Phuket sees Covid-19 surge, lax prevention and booster shot issues
Rising Covid-19 cases in Phuket linked to lax preventive measures and lack of booster shots; herbal medicine gains popularity.
Go deeper with Google Headlines on:
Prevention and treatment of COVID-19
[google_news title=”” keyword=”prevention and treatment of COVID-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
